Successful Immunization of Humans with Irradiated Malaria Sporozoites: Humoral and Cellular Responses of the Protected Individuals

Deirdre HerringtonCenter for Vaccine Development, Departments of Medicine and Pediatrics, and Department of Radiation Oncology, University of Maryland at Baltimore, Department of Medical and Molecular Parasitology, New York University School of Medicine, Biomedical Research Institute, Baltimore, Maryland

Search for other papers by Deirdre Herrington in
Current site
Google Scholar
PubMed
Close
,
Jonathan DavisCenter for Vaccine Development, Departments of Medicine and Pediatrics, and Department of Radiation Oncology, University of Maryland at Baltimore, Department of Medical and Molecular Parasitology, New York University School of Medicine, Biomedical Research Institute, Baltimore, Maryland

Search for other papers by Jonathan Davis in
Current site
Google Scholar
PubMed
Close
,
Elizabeth NardinCenter for Vaccine Development, Departments of Medicine and Pediatrics, and Department of Radiation Oncology, University of Maryland at Baltimore, Department of Medical and Molecular Parasitology, New York University School of Medicine, Biomedical Research Institute, Baltimore, Maryland

Search for other papers by Elizabeth Nardin in
Current site
Google Scholar
PubMed
Close
,
Magda BeierCenter for Vaccine Development, Departments of Medicine and Pediatrics, and Department of Radiation Oncology, University of Maryland at Baltimore, Department of Medical and Molecular Parasitology, New York University School of Medicine, Biomedical Research Institute, Baltimore, Maryland

Search for other papers by Magda Beier in
Current site
Google Scholar
PubMed
Close
,
Joseph CorteseCenter for Vaccine Development, Departments of Medicine and Pediatrics, and Department of Radiation Oncology, University of Maryland at Baltimore, Department of Medical and Molecular Parasitology, New York University School of Medicine, Biomedical Research Institute, Baltimore, Maryland

Search for other papers by Joseph Cortese in
Current site
Google Scholar
PubMed
Close
,
Hubert EddyCenter for Vaccine Development, Departments of Medicine and Pediatrics, and Department of Radiation Oncology, University of Maryland at Baltimore, Department of Medical and Molecular Parasitology, New York University School of Medicine, Biomedical Research Institute, Baltimore, Maryland

Search for other papers by Hubert Eddy in
Current site
Google Scholar
PubMed
Close
,
Genevieve LosonskyCenter for Vaccine Development, Departments of Medicine and Pediatrics, and Department of Radiation Oncology, University of Maryland at Baltimore, Department of Medical and Molecular Parasitology, New York University School of Medicine, Biomedical Research Institute, Baltimore, Maryland

Search for other papers by Genevieve Losonsky in
Current site
Google Scholar
PubMed
Close
,
Michael HollingdaleCenter for Vaccine Development, Departments of Medicine and Pediatrics, and Department of Radiation Oncology, University of Maryland at Baltimore, Department of Medical and Molecular Parasitology, New York University School of Medicine, Biomedical Research Institute, Baltimore, Maryland

Search for other papers by Michael Hollingdale in
Current site
Google Scholar
PubMed
Close
,
Marcelo SzteinCenter for Vaccine Development, Departments of Medicine and Pediatrics, and Department of Radiation Oncology, University of Maryland at Baltimore, Department of Medical and Molecular Parasitology, New York University School of Medicine, Biomedical Research Institute, Baltimore, Maryland

Search for other papers by Marcelo Sztein in
Current site
Google Scholar
PubMed
Close
,
Myron LevineCenter for Vaccine Development, Departments of Medicine and Pediatrics, and Department of Radiation Oncology, University of Maryland at Baltimore, Department of Medical and Molecular Parasitology, New York University School of Medicine, Biomedical Research Institute, Baltimore, Maryland

Search for other papers by Myron Levine in
Current site
Google Scholar
PubMed
Close
,
Ruth S. NussenzweigCenter for Vaccine Development, Departments of Medicine and Pediatrics, and Department of Radiation Oncology, University of Maryland at Baltimore, Department of Medical and Molecular Parasitology, New York University School of Medicine, Biomedical Research Institute, Baltimore, Maryland

Search for other papers by Ruth S. Nussenzweig in
Current site
Google Scholar
PubMed
Close
,
David ClydeCenter for Vaccine Development, Departments of Medicine and Pediatrics, and Department of Radiation Oncology, University of Maryland at Baltimore, Department of Medical and Molecular Parasitology, New York University School of Medicine, Biomedical Research Institute, Baltimore, Maryland

Search for other papers by David Clyde in
Current site
Google Scholar
PubMed
Close
, and
Robert EdelmanCenter for Vaccine Development, Departments of Medicine and Pediatrics, and Department of Radiation Oncology, University of Maryland at Baltimore, Department of Medical and Molecular Parasitology, New York University School of Medicine, Biomedical Research Institute, Baltimore, Maryland

Search for other papers by Robert Edelman in
Current site
Google Scholar
PubMed
Close
Restricted access

Two groups of volunteers were vaccinated by repeated exposure to the bites of Plasmodium falciparum-infected, x-irradiated mosquitoes in order to characterize the humoral and cellular immune responses of sporozoite-immunized, protected individuals. One of the two volunteers in the first immunization trial, when challenged by the bite of P. falciparum-infected mosquitoes, developed an infection only after a prolonged prepatent period. A second group of three volunteers who were exposed more frequently to larger numbers of infected mosquitoes irradiated with a lower x-ray dose was completely protected against sporozoite challenge. These individuals and the volunteer with delayed infection had high levels of antibodies to sporozoites and to the repeat region of the circumsporozoite (CS) protein. The CS-specific cellular immune responses of these volunteers were also stimulated by sporozoite immunization, as determined by proliferation of peripheral blood mononuclear cells (PBMC) and mitogen or antigen-expanded PBMC, in response to in vitro challenge with a recombinant P. falciparum CS protein. Based upon the assays used in this study, it is not possible to reach conclusions regarding specific immunologic responses and protection from sporozoite challenge.

Save